Skip to main content
Skip to primary sidebar
Skip to footer

240.243.1201
info@glycomimetics.com

Careers
Contact Us

About Us
Patients
- Clinical Trials
- Expanded Access
Pipeline
- Programs
- Therapeutic Focus
  - Acute Myeloid Leukemia (AML)
Technology & Publications
Collaborations
Investors
Careers
Contact Us
Search

Search

Primary Sidebar

News

February 25, 2020
GlycoMimetics to Present at the Cowen and Company 40th Annual Health Care Conference 2020

February 4, 2020
GlycoMimetics Advances GMI-1359 Program With Patent Issuance and FDA Designations

January 30, 2020
First Patient With Advanced Breast Cancer Receives First Dose in Clinical Trial of GlycoMimetics’ GMI-1359

January 6, 2020
GlycoMimetics and Apollomics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Uproleselan and GMI-1687 in Greater China

Footer

Questions?

Contact GlycoMimetics Today

© GlycoMimetics All rights reserved. Website Design & Development: Graphic Beans

Site Map | Terms of Use | Privacy | Contact Us